Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients

LASCA may safely monitor DU evolution in SSc patients, by evaluating its blood perfusion and area during standard treatment. This may be useful to monitor DU evolution during treatment in clinical trials.